Comparing JC virus DNA detection by PCR with JC virus antibody testing to identify natalizumab-treated patients previously exposed to JC virus

被引：0
|
作者：
Kinsella, K.
Kelly, S. B.
De Gascun, C. F.
Carr, M.
Duggan, M.
Hutchinson, M.
Tubridy, N.
McGuigan, C.
机构：
[1] St Vincents Univ Hosp, Dublin 4, Ireland
[2] UCD, Natl Virus Ref Lab, Dublin, Ireland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P533
引用
收藏
页码：S230 / S230
页数：1
相关论文
共 50 条
  • [21] Evaluation of the Incidence of Anti-JC Virus Antibodies in a Cohort of Natalizumab-Treated Patients
    Pepio, Anthony M.
    Mocci, Simonetta
    Taylor, Julie
    Taylor, Lori
    Yednock, Ted
    Gorelik, Leonid
    Goelz, Susan
    Subramanyam, Meena
    GASTROENTEROLOGY, 2010, 138 (05) : S146 - S146
  • [22] Evaluation of the Incidence of Anti-JC Virus Antibodies in a Cohort of Natalizumab-Treated Patients
    Pepio, Anthony
    Taylor, Lori
    Jaros, Mark
    Mocci, Simonetta
    Taylor, Julie
    Yednock, Ted
    Plavina, Tatiana
    Gorelik, Leonid
    Goelz, Susan
    Subramanyam, Meena
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S432 - S432
  • [23] Therapeutic decision after JC virus testing in a cohort of patients treated with natalizumab
    Ongagna, J. C.
    Courtois, S.
    Gaultier, C.
    Kopf, A.
    Fleury, M. C.
    Ahle, G.
    Collongues, N.
    Chanson, J. P.
    Marcel, C.
    Blanc, F.
    De Seze, J.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 208 - 209
  • [24] Cerebrospinal fluid and serum JC virus antibody detection in multiple sclerosis patients treated with natalizumab
    Lin, Jerry
    Bettin, Peggy
    Lee, John K.
    Ho, Joseph K.
    Sadiq, Saud A.
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 261 (1-2) : 123 - 128
  • [25] Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab REPLY
    Tan, Chen S.
    Kinkel, R. Philip
    Koralnik, Igor J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25): : 2489 - 2490
  • [26] Evaluation of the incidence of anti-JC virus antibodies in a cohort of natalizumab-treated patients.
    Pepio, A.
    Taylor, L.
    Jaros, M.
    Mocci, S.
    Taylor, J.
    Yednock, T.
    Plavina, T.
    Gorelik, L.
    Goelz, S.
    Subramanyam, M.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S36 - S36
  • [27] Cellular response to JC virus: a longitudinal study in a population of natalizumab-treated multiple sclerosis patients
    Masera, S.
    Costa, C.
    Dematteis, F.
    Superti, G.
    Romagnolo, A.
    Mattioda, A.
    Pinessi, L.
    Lopiano, L.
    Cavallo, R.
    Cavalla, P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 232 - 233
  • [28] qPCR versus two-step ELISA to detect JC virus in natalizumab-treated patients
    Dominguez-Mozo, M. I.
    Garcia-Montojo, M.
    De las Heras, V.
    Garcia-Martinez, M. A.
    Arias-Leal, A.
    Casanova, I.
    Arroyo, R.
    Alvarez-Lafuente, R.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 141 - 142
  • [29] Use of JC virus antibody index to stratify risk of progressive multifocal leukoencephalopathy in natalizumab-treated patients with multiple sclerosis
    Plavina, T.
    Subramanyam, M.
    Bloomgren, G.
    Richman, S.
    Pace, A.
    Lee, S.
    Schlain, B.
    Campagnolo, D.
    Ticho, B.
    JOURNAL OF NEUROLOGY, 2013, 260 : S13 - S13
  • [30] Prevalence of anti-JC virus antibodies in a cohort of 1'200 natalizumab-treated MS patients
    Radji, F.
    Outteryck, O.
    Zephir, H.
    Ongagna, J. C.
    Brochet, B.
    Ouallet, J. C.
    Rumbach, L.
    Lebrun-Frenay, C.
    Debouverie, M.
    Pittion, S.
    Laplaud, D.
    Wiertlewski, S.
    Cabre, P.
    Confavreux, C.
    Vukusic, S.
    Pelletier, J.
    Audouin, B.
    Defer, G.
    Derache, N.
    Camu, W.
    Thouvenot, E.
    Tourbah, A.
    Labauge, P.
    Moreau, T.
    Fromont, A.
    Castelnovo, G.
    Clavelou, P.
    Casez, O.
    Hautecoeur, P.
    Papeix, C.
    Couturier, N.
    Viala, F.
    Liblau, R.
    Clanet, M.
    De Seze, J.
    Vermersch, P.
    Brassat, D.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S216 - S216
12345